References
- Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191–7
- Ahmad MZ, Akhter S, Anwar M, et al. Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation. Drug Dev Ind Pharm 2013;39:1936–43
- Bleiberg H, Vandebroek A, Deleu I, et al. A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer. Acta Gastroenterol Belg 2012;75:14–21
- Patel VB, Misra S, Patel BB, Majumdar APN. Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Can 2010;62:958–67
- Kelloff GJ, Crowell JA, Steele VE, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000;130:467S–71S
- Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007;595:1–75
- Gao M, Xu H, Zhang C, et al. Preparation and characterization of curcumin thermosensitive hydrogels for intratumoral injection treatment. Drug Dev Ind Pharm 2014;40:1557–64
- Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1–7
- Kumar V, Lewis SA, Mutalik S, et al. Biodegradable microspheres of curcumin for treatment of inflammation. Ind J Physiol Pharmacol 2002;46:209–17
- Takahashi M, Uechi S, Takara K, et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome encapsulated curcumin. J Agric Food Chem 2009;57:9141–6
- Bansal SS, Kausar H, Vadhanam MV, et al. Controlled systemic delivery by polymeric implants enhances tissue and plasma curcumin levels compared with oral administration. Euro J Pharm Biopharm 2012;80:571–7
- Gao Y, Li Z, Sun M, et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm 2010;36:1225–34
- Zhongfa L, Chiu M, Wang J, et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 2012;69:679–89
- Feng R, Song Z, Zhai G. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL–PEG–PCL tri-block copolymeric nanoparticles. Int J Nanomed 2012;7:4089–98
- Setthacheewakul S, Mahattanadul S, Phadoongsombut N, et al. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin and absorption studies in rats. Eur J Pharm Biopharm 2010;76:475–85
- Gota VS, Maru GB, Soni TG, et al. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010;58:2095–9
- Arya P, Pathak K. Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics. Int J Pharm 2014;460:1–12
- Ratnam DV, Ankola DD,Bhardwaj V, et al. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 2006;113:189–207
- Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, et al. Comparison of physicochemical characteristics and drug release of diclofenac sodium–eudragit® RS100 nanoparticles and solid dispersions. Powder Technol 2012;219:211–16
- Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumor delivery by EPR effect. Adv Drug Del Rev 2001;63:170–83
- Jung JY, Yoo SD, Lee SH, et al. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm 1999;187:209–18
- Wang SL, Lin SY, Chen TF, Cheng WT. Eudragit E accelerated the diketopiperazine formation of enalapril maleate determined by thermal FTIR microspectroscopic technique. Pharm Res 2004;21:2127–32
- Chaurasia S, Kumar N, Patel RR, Mishra B. Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using Taguchi robust design. Adv Sci Lett 2014;20:1028–38
- Vichai V, Kirtikara K. Sulforhodamine B. Colorimetric assay for cytotoxicity screening. Nat Protocols 2006;1:1112–16
- Meier J, Nuesch E, Schmidt R. Pharmacokinetic criteria for the evaluation of retard formulations. Eur J Clin Pharmacol 1974;76:429–32
- Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–63
- Lim S, Shin DH, Choi M, Kim J. Enhanced antitumor efficacy of gemcitabine-loaded temperature sensitive liposome by hyperthermia in tumor-bearing mice. Drug Dev Ind Pharm 2014;40:470–6
- Morton CL, Papa RA, Lock RB, Houghton PJ. Preclinical chemotherapeutic tumor models of common childhood cancers: solid tumors, acute lymphoblastic leukemia and disseminated neuroblastoma. Cur Protocol Pharmacol 2007;39:14.8.1–14.8.21
- Fessi H, Puisieux F, Devissaguet JP, et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:R1
- Briscoe BJ, Lawrence CJ, Mietus WGP. A review of immiscible fluid mixing. Adv Colloid Interface Sci 1999;81:1–17
- Kwon HY, Lee JY, Choi SW, et al. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloid Surf A 2001;182:123–30
- Poletto FS, Fiel LA, Donida B, et al. Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification–diffusion technique using ethanol as surface agent. Colloid Surf A 2008;324:105–12
- Oliveira AMD, Jäger E, Jäger A, et al. Physicochemical aspects behind the size of biodegradable polymeric nanoparticles: a step forward. Colloids Surf A 2013;436:1092–102
- Yousefi A, Esmaeili F, Rahimian S, et al. Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel. Sci Pharm 2009;77:453–64
- Das M, Sahoo SK. Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy. Acta Biomater 2010;7:355–69
- Sahoo SK, Labhestwar V. Enhanced antiproliferative activity of transferrin conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2005;2:373–83
- Wang XQ, Dai JD, Zhang H, et al. absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol 2008;8:2422–31
- Janssens S, De Zeure A, Paudel A, et al. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and Eudragit E 100. Pharm Res 2010;27:775–85
- Bhardwaj V, Ankola DD, Gupta SC, et al. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharma Res 2009;26:2495–503
- Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1–16